Hybrid alpha-amylases
AssigneeDanisco US Inc.
InventorsScott D. Power, Andrew Shaw
Life of this patent
Estimating the term…
Loading patent…
AssigneeDanisco US Inc.
InventorsScott D. Power, Andrew Shaw
Estimating the term…
Hybrid alpha-amylases are provided that share a conserved 3D structure in whole or in part with a wild-type Termamyl-like α-amylase, e.g., a Bacillus amylase. In the hybrid, an N-terminal portion of a Termamyl-like α-amylase is replaced with sequences from an archae α-amylase. The sequence similarity between the two amylase sequences may be less than 60%. Conserving the wild-type 3D structure in the hybrid facilitates obtaining enzymatically active amylases. In one embodiment, one or both amylase sequences contribute residues to the B domain, resulting in particularly advantageous properties. For instance, replacement of the Ca2+ binding site in the B domain of the Termamyl-like α-amylase with a B domain sequence of an archae α-amylase that does not bind Ca2+ can produce a hybrid that is fully active in the absence of Ca2+.
An enzymatically active hybrid α-amylase comprising a polypeptide having, from N-terminus to C-terminus, a first amino acid sequence from an archae α-amylase and a second amino acid sequence from a wild-type Termamyl-like α-amylase or a variant thereof having at least 80% sequence identity to the wild-type Termamyl-like α-amylase;
Dependencies are inferred from the claim text.